104 related articles for article (PubMed ID: 20938363)
1. Localization of HtrA2/Omi immunoreactivity in brains affected by Alzheimer's disease.
Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Takahashi R
Neuroreport; 2010 Dec; 21(17):1121-5. PubMed ID: 20938363
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi.
Park HJ; Seong YM; Choi JY; Kang S; Rhim H
Neurosci Lett; 2004 Feb; 357(1):63-7. PubMed ID: 15036614
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of X-linked inhibitor of apoptosis protein in brainstem-type and cortical Lewy bodies.
Kawamoto Y; Ito H; Ihara M; Takahashi R
Neuroreport; 2012 Feb; 23(3):162-7. PubMed ID: 22273571
[TBL] [Abstract][Full Text] [Related]
4. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis.
Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R
Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124
[TBL] [Abstract][Full Text] [Related]
5. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.
Althaus J; Siegelin MD; Dehghani F; Cilenti L; Zervos AS; Rami A
Neurochem Int; 2007 Jan; 50(1):172-80. PubMed ID: 16978742
[TBL] [Abstract][Full Text] [Related]
6. Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease.
Westerlund M; Behbahani H; Gellhaar S; Forsell C; Belin AC; Anvret A; Zettergren A; Nissbrandt H; Lind C; Sydow O; Graff C; Olson L; Ankarcrona M; Galter D
FASEB J; 2011 Apr; 25(4):1345-52. PubMed ID: 21163861
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies.
Kawamoto Y; Kobayashi Y; Suzuki Y; Inoue H; Tomimoto H; Akiguchi I; Budka H; Martins LM; Downward J; Takahashi R
J Neuropathol Exp Neurol; 2008 Oct; 67(10):984-93. PubMed ID: 18800009
[TBL] [Abstract][Full Text] [Related]
8. Association of Omi/HtrA2 with γ-secretase in mitochondria.
Behbahani H; Pavlov PF; Wiehager B; Nishimura T; Winblad B; Ankarcrona M
Neurochem Int; 2010 Nov; 57(6):668-75. PubMed ID: 20705111
[TBL] [Abstract][Full Text] [Related]
9. Proteome-wide Identification of HtrA2/Omi Substrates.
Vande Walle L; Van Damme P; Lamkanfi M; Saelens X; Vandekerckhove J; Gevaert K; Vandenabeele P
J Proteome Res; 2007 Mar; 6(3):1006-15. PubMed ID: 17266347
[TBL] [Abstract][Full Text] [Related]
10. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
Papasozomenos SC
Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
[TBL] [Abstract][Full Text] [Related]
11. Archival, formalin-fixed tissue: its use in the study of Alzheimer's type changes.
Dwork AJ; Liu D; Kaufman MA; Prohovnik I
Clin Neuropathol; 1998; 17(1):45-9. PubMed ID: 9496540
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice with neuron-specific overexpression of HtrA2/Omi suggest a neuroprotective role for HtrA2/Omi.
Liu MJ; Liu ML; Shen YF; Kim JM; Lee BH; Lee YS; Hong ST
Biochem Biophys Res Commun; 2007 Oct; 362(2):295-300. PubMed ID: 17707776
[TBL] [Abstract][Full Text] [Related]
13. [Apolipoprotein B immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in senile dementia of Alzheimer type].
Namba Y; Ikeda K
Rinsho Shinkeigaku; 1991 Aug; 31(8):826-30. PubMed ID: 1764857
[TBL] [Abstract][Full Text] [Related]
14. Increased Active OMI/HTRA2 Serine Protease Displays a Positive Correlation with Cholinergic Alterations in the Alzheimer's Disease Brain.
Darreh-Shori T; Rezaeianyazdi S; Lana E; Mitra S; Gellerbring A; Karami A; Bogdanovic N; Lithner CU; Winblad B; Behbahani H
Mol Neurobiol; 2019 Jul; 56(7):4601-4619. PubMed ID: 30361890
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
Li W; Srinivasula SM; Chai J; Li P; Wu JW; Zhang Z; Alnemri ES; Shi Y
Nat Struct Biol; 2002 Jun; 9(6):436-41. PubMed ID: 11967569
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
[TBL] [Abstract][Full Text] [Related]
18. Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level.
Xu Z; Chen Y; Xu G; Peng C; Liu E; Li Y; Niu J; Li C
Oncol Rep; 2015 Feb; 33(2):905-12. PubMed ID: 25484138
[TBL] [Abstract][Full Text] [Related]
19. Alpha 1-trypsin immunoreactivity in Alzheimer disease.
Smith MA; Kalaria RN; Perry G
Biochem Biophys Res Commun; 1993 Jun; 193(2):579-84. PubMed ID: 8512558
[TBL] [Abstract][Full Text] [Related]
20. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.
Shin RW; Iwaki T; Kitamoto T; Tateishi J
Lab Invest; 1991 May; 64(5):693-702. PubMed ID: 1903170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
